BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang S, Li Y, Qiao J, Meng X, He Z, Gao X, Yu L. Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges. Front Oncol 2022;12:787108. [PMID: 35356211 DOI: 10.3389/fonc.2022.787108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Greiner J, Goetz M, Schuler PJ, Bulach C, Hofmann S, Schrezenmeier H, Dӧhner H, Schneider V, Guinn BA. Enhanced stimulation of antigen-specific immune responses against nucleophosmin 1 mutated acute myeloid leukaemia by an anti-programmed death 1 antibody. Br J Haematol 2022. [PMID: 35799423 DOI: 10.1111/bjh.18326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Keller AL, Sherbenou DW, Forsberg PA, Mark TM. Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm. Front Oncol 2022;12:925818. [DOI: 10.3389/fonc.2022.925818] [Reference Citation Analysis]
3 Khaldoyanidi SK, Hindoyan A, Stein A, Subklewe M. Leukemic Stem Cells as a Target for Eliminating Acute Myeloid Leukemia: Gaps in Translational Research. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]